Bristol-Myers Squibb
BMY
BMY
2,455 hedge funds and large institutions have $97.2B invested in Bristol-Myers Squibb in 2025 Q1 according to their latest regulatory filings, with 199 funds opening new positions, 944 increasing their positions, 977 reducing their positions, and 166 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 2,468 → 2,455 (-13)
3% less repeat investments, than reductions
Existing positions increased: 944 | Existing positions reduced: 977
10% less funds holding in top 10
Funds holding in top 10: 39 → 35 (-4)
Holders
2,455
Holding in Top 10
35
Calls
$1.73B
Puts
$1.7B
Top Buyers
| 1 | +$1.26B | |
| 2 | +$1.08B | |
| 3 | +$734M | |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$730M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$281M |
Top Sellers
| 1 | -$579M | |
| 2 | -$484M | |
| 3 | -$355M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$300M |
| 5 |
VanEck Associates
New York
|
-$249M |